Morgan Stanley Maintains Equal-Weight on Phibro Animal Health, Raises Price Target to $21
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Morgan Stanley analyst Erin Wright maintains Phibro Animal Health (NASDAQ:PAHC) with a Equal-Weight and raises the price target from $20 to $21.
Morgan Stanley analyst Erin Wright maintains Phibro Animal Health (NASDAQ:PAHC) with a Equal-Weight and raises the price target from $20 to $21.